Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related BAX
Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy
What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts
Merck Snags Baxter Executive As CFO (Fox Business)
Related CVC
A Look At Liberty Global Amid Cablevision Systems' Downgrade
These Stocks Were Rocked In Mid-Day Trading
J-Lo-Backed Network Outbids 'Diddy' for Fuse (Fox Business)

Analysts at Mizuho downgraded Baxter International (NYSE: BAX) from “buy” to “neutral.” Baxter's shares closed at $66.84 yesterday. Baxter's trailing-twelve-month profit margin is 16.36%.

Analysts at Canaccord downgraded Cablevision Systems (NYSE: CVC) from “buy” to “hold.” Cablevision's shares closed at $14.02 yesterday. Cablevision's trailing-twelve-month ROA is 9.77%.

Analysts at RBC Capital downgraded McMoRan Exploration Co (NYSE: MMR) from “outperform” to “sector perform.” McMoRan Exploration's shares closed at $9.65 yesterday. McMoRan Exploration's PEG ratio is -4.48.

Bernstein downgraded Boston Scientific (NYSE: BSX) from “outperform” to “market perform.” Boston Scientific's shares closed at $5.66 yesterday. Boston Scientific's trailing-twelve-month ROE is -43.84%.

Latest Ratings for BAX

DateFirmActionFromTo
Oct 2014BarclaysMaintainsOverweight
Oct 2014Credit SuisseMaintainsOutperform
Oct 2014Morgan StanleyMaintainsEqual-weight

View More Analyst Ratings for BAX
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BAX + BSX)

Around the Web, We're Loving...

Get Benzinga's Newsletters